Showing results (1821-1830 of 1,911) with videos related to

Sort By:
Pageof 192
NIHR Open Research|October 26, 2023
Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trialSophie M C Green, Louise H Hall, Nikki Rousseau, et al.
Research Square|July 3, 2023
Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosisMasayuki Umeda, Jing Ma, Tamara Westover, et al.
Psycho-Oncology|May 16, 2024
A pilot randomised controlled trial of acceptance and commitment therapy for medication decision-making and quality of life in women with breast cancer: The ACTION trialChristopher D Graham, Rachel Ellison, Louise H Hall, et al.
BMJ Open|February 3, 2023
Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trialSamuel G Smith, Sophie M C Green, Rachel Ellison, et al.
Implementation Science : IS|May 26, 2022
A randomised fractional factorial screening experiment to predict effective features of audit and feedbackAlexandra Wright-Hughes, Thomas A Willis, Stephanie Wilson, et al.
Nature Biotechnology|June 3, 2000
Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arraysS Brenner, M Johnson, J Bridgham, et al.
Prevention Science : the Official Journal of the Society for Prevention Research|July 26, 2024
Acceptability of Four Intervention Components Supporting Medication Adherence in Women with Breast Cancer: a Process Evaluation of a Fractional Factorial Pilot Optimization TrialSophie M C Green, Nikki Rousseau, Louise H Hall, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung CancerAlessia Catozzi, Maria Peiris-Pagès, Sam Humphrey, et al.
European Journal of Cancer (Oxford, England : 1990)|August 29, 2022
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patientsJean-Philippe Foy, Andy Karabajakian, Sandra Ortiz-Cuaran, et al.
Future Oncology (London, England)|July 29, 2025
ABC-12: exploring the microbiome in patients with advanced biliary tract cancer in a first-line study of durvalumab (MEDI4736) in combination with cisplatin/gemcitabineEleni Vrana, Hayley Timmins, Ashley Osborne, et al.
Pageof 192